These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 8088369)

  • 1. Calcium channel blockers inhibit the (Ca2+ + Mg2+)-ATPase activity and the 125I-calmodulin binding in brain membranes.
    Santos DL; Lopes MC; Carvalho CM
    Eur J Pharmacol; 1994 May; 267(3):307-16. PubMed ID: 8088369
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Calmodulin-stimulated plasma membrane (Ca2+ + Mg2+)-ATPase: inhibition by calcium channel entry blockers.
    Raess BU; Gersten MH
    Biochem Pharmacol; 1987 Aug; 36(15):2455-9. PubMed ID: 3038124
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between human erythrocyte calmodulin and the cytoplasmic surface of human erythrocyte membranes.
    Agre P; Gardner K; Bennett V
    J Biol Chem; 1983 May; 258(10):6258-65. PubMed ID: 6133862
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Partition of Ca2+ antagonists in brain plasma membranes.
    Carvalho CM; Oliveira CR; Lima MP; Leysen JE; Carvalho AP
    Biochem Pharmacol; 1989 Jul; 38(13):2121-7. PubMed ID: 2735950
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stimulation of canine cardiac sarcoplasmic reticulum Ca2+ uptake by dihydropyridine Ca2+ antagonists.
    Movsesian MA; Ambudkar IS; Adelstein RS; Shamoo AE
    Biochem Pharmacol; 1985 Jan; 34(2):195-201. PubMed ID: 3155615
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of Ca2+ channel blockers on Ca2+ translocation across synaptosomal membranes.
    Carvalho CA; Coutinho OP; Carvalho AP
    J Neurochem; 1986 Dec; 47(6):1774-84. PubMed ID: 2430061
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of felodipine (a dihydropyridine calcium channel blocker) and analogues on calmodulin-dependent enzymes.
    Walsh MP; Sutherland C; Scott-Woo GC
    Biochem Pharmacol; 1988 Apr; 37(8):1569-80. PubMed ID: 2833901
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bepridil and cetiedil. Vasodilators which inhibit Ca2+-dependent calmodulin interactions with erythrocyte membranes.
    Agre P; Virshup D; Bennett V
    J Clin Invest; 1984 Sep; 74(3):812-20. PubMed ID: 6088585
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Opiates inhibit calmodulin activation of a high-affinity Ca2+-stimulated Mg2+-dependent ATPase in synaptic membranes.
    Ross DH; Cardenas HL
    Neurochem Res; 1987 Jan; 12(1):41-8. PubMed ID: 2952897
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of the (Ca2+-Mg2+)ATPase purified by calmodulin-affinity chromatography from bovine aortic smooth muscle.
    Furukawa K; Nakamura H
    J Biochem; 1984 Nov; 96(5):1343-50. PubMed ID: 6151947
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of trifluoperazine, compound 48/80, TMB-8 and verapamil on the rate of calmodulin binding to erythrocyte Ca2+-ATPase.
    Scharff O; Foder B
    Biochim Biophys Acta; 1984 Apr; 772(1):29-36. PubMed ID: 6231956
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of long-term treatment with the Ca2(+)-antagonists nifedipine, verapamil, flunarizine and with the calmodulin antagonist trifluoperazine on beta-adrenoceptors in rat cerebral cortex.
    Staneva-Stoytcheva D; Popova J; Mutafova-Yambolieva V; Alov P
    Gen Pharmacol; 1990; 21(1):149-52. PubMed ID: 2153606
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A monoclonal antibody to the calmodulin-binding (Ca2+ + Mg2+)-dependent ATPase from pig stomach smooth muscle inhibits plasmalemmal (Ca2+ + Mg2+)-dependent ATPase activity.
    Verbist J; Wuytack F; Raeymaekers L; Van Leuven F; Cassiman JJ; Casteels R
    Biochem J; 1986 Dec; 240(3):633-40. PubMed ID: 2950852
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Ca(2+)+Mg2+]-dependent ATPase activity in rat pineal gland.
    Chen LD; Manchester LC; Reiter RJ; Tan DX; Poeggeler B
    Neurosci Lett; 1993 Jul; 157(2):131-4. PubMed ID: 8233042
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of erythrocyte Ca2(+)-pump by Ca2+ antagonists.
    Raess BU; Record DM
    Biochem Pharmacol; 1990 Dec; 40(11):2549-55. PubMed ID: 2148481
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An endogenous inhibitor protein of synaptic plasma membrane (Ca2+ + Mg2+)-ATPase.
    Au KS; Cho KL; Lee KS; Lai KM
    Biochim Biophys Acta; 1985 Dec; 821(2):348-54. PubMed ID: 2933075
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of calcium antagonists on heart sarcolemmal (Na+ + K(+)-ATPase.
    Dzurba A; Breier A; Slezák J; Stankovicová T; Vrbjar N; Ziegelhöffer A
    Bratisl Lek Listy; 1991; 92(3-4):155-8. PubMed ID: 1851463
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Verapamil, diltiazem and nifedipine interactions with calmodulin stimulated (Ca2+ + Mg2+)-ATPase.
    Kim HC; Raess BU
    Biochem Pharmacol; 1988 Mar; 37(5):917-20. PubMed ID: 2964236
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of the Ca2(+)-antagonists nifedipine, verapamil, flunarizine and of the calmodulin antagonist trifluoperazine on muscarinic cholinergic receptors in rat cerebral cortex.
    Popova J; Staneva-Stoytcheva D; Mutafova V
    Gen Pharmacol; 1990; 21(3):317-9. PubMed ID: 2341018
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glucose inhibits the high-affinity (Ca2+ + Mg2+)-ATPase in the plasma membrane of a glucose-responsive insulinoma.
    Hoenig M; Lee RJ; Ferguson DC
    Biochim Biophys Acta; 1990 Mar; 1022(3):333-8. PubMed ID: 2156557
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.